カテゴリー： 世界, 医療/バイオ, QYResearch

ファーマコゲノミクス（PGx）サービスの世界市場インサイト・予測（～2028年）

【英語タイトル】Global Pharmacogenomics Services Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX09275）・商品コード：QY22JLX09275
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：110
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、ファーマコゲノミクス（PGx）サービスのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にファーマコゲノミクス（PGx）サービスの世界市場のxxx％を占める「ジェノタイピング」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「腫瘍」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
ファーマコゲノミクス（PGx）サービスの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのファーマコゲノミクス（PGx）サービス市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ファーマコゲノミクス（PGx）サービスのグローバル主要企業には、Abbott Laboratories、Admera Health, LLC、Mesa Laboratories, Inc.、Dynamic DNA Laboratories、F. Hoffmann-La Roche Ltd.、GeneOmbio Technologies Pvt Ltd.、Exact Sciences Corporation、Illumina, Inc.、Laboratory Corporation of America Holdings、Myriad Genetics, Inc.、OmeCare、QIAGEN N.V.、Quest Diagnostics Incorporated、Thermo Fisher Scientific Inc.、Precipio、23andMe, Inc.、OneOme, LLC、DiaCarta, Inc.、OPKO Healthなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ファーマコゲノミクス（PGx）サービス市場は、種類と用途によって区分されます。世界のファーマコゲノミクス（PGx）サービス市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
ジェノタイピング、SNP同定、薬理遺伝学的検査、その他

【用途別セグメント】
腫瘍、感染症、精神医療、心臓血管、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ファーマコゲノミクス（PGx）サービス製品概要
- 種類別市場（ジェノタイピング、SNP同定、薬理遺伝学的検査、その他）
- 用途別市場（腫瘍、感染症、精神医療、心臓血管、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のファーマコゲノミクス（PGx）サービス販売量予測2017-2028
- 世界のファーマコゲノミクス（PGx）サービス売上予測2017-2028
- ファーマコゲノミクス（PGx）サービスの地域別販売量
- ファーマコゲノミクス（PGx）サービスの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ファーマコゲノミクス（PGx）サービス販売量
- 主要メーカー別ファーマコゲノミクス（PGx）サービス売上
- 主要メーカー別ファーマコゲノミクス（PGx）サービス価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（ジェノタイピング、SNP同定、薬理遺伝学的検査、その他）
- ファーマコゲノミクス（PGx）サービスの種類別販売量
- ファーマコゲノミクス（PGx）サービスの種類別売上
- ファーマコゲノミクス（PGx）サービスの種類別価格
・用途別市場規模（腫瘍、感染症、精神医療、心臓血管、その他）
- ファーマコゲノミクス（PGx）サービスの用途別販売量
- ファーマコゲノミクス（PGx）サービスの用途別売上
- ファーマコゲノミクス（PGx）サービスの用途別価格
・北米市場
- 北米のファーマコゲノミクス（PGx）サービス市場規模（種類別、用途別）
- 主要国別のファーマコゲノミクス（PGx）サービス市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのファーマコゲノミクス（PGx）サービス市場規模（種類別、用途別）
- 主要国別のファーマコゲノミクス（PGx）サービス市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のファーマコゲノミクス（PGx）サービス市場規模（種類別、用途別）
- 主要国別のファーマコゲノミクス（PGx）サービス市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のファーマコゲノミクス（PGx）サービス市場規模（種類別、用途別）
- 主要国別のファーマコゲノミクス（PGx）サービス市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのファーマコゲノミクス（PGx）サービス市場規模（種類別、用途別）
- 主要国別のファーマコゲノミクス（PGx）サービス市場規模（トルコ、サウジアラビア）
・企業情報
Abbott Laboratories、Admera Health, LLC、Mesa Laboratories, Inc.、Dynamic DNA Laboratories、F. Hoffmann-La Roche Ltd.、GeneOmbio Technologies Pvt Ltd.、Exact Sciences Corporation、Illumina, Inc.、Laboratory Corporation of America Holdings、Myriad Genetics, Inc.、OmeCare、QIAGEN N.V.、Quest Diagnostics Incorporated、Thermo Fisher Scientific Inc.、Precipio、23andMe, Inc.、OneOme, LLC、DiaCarta, Inc.、OPKO Health
・産業チェーン及び販売チャネル分析
- ファーマコゲノミクス（PGx）サービスの産業チェーン分析
- ファーマコゲノミクス（PGx）サービスの原材料
- ファーマコゲノミクス（PGx）サービスの生産プロセス
- ファーマコゲノミクス（PGx）サービスの販売及びマーケティング
- ファーマコゲノミクス（PGx）サービスの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ファーマコゲノミクス（PGx）サービスの産業動向
- ファーマコゲノミクス（PGx）サービスのマーケットドライバー
- ファーマコゲノミクス（PGx）サービスの課題
- ファーマコゲノミクス（PGx）サービスの阻害要因
・主な調査結果

Market Analysis and Insights: Global Pharmacogenomics Services Market
The global Pharmacogenomics Services market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Genotyping accounting for % of the Pharmacogenomics Services global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Oncology segment is altered to an % CAGR throughout this forecast period.
China Pharmacogenomics Services market size is valued at US$ million in 2021, while the North America and Europe Pharmacogenomics Services are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pharmacogenomics Services landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmacogenomics Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmacogenomics Services market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmacogenomics Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmacogenomics Services market.
Global Pharmacogenomics Services Scope and Market Size
Pharmacogenomics Services market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pharmacogenomics Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Genotyping
SNP Identification
Pharmacogenetic Testing
Others
Segment by Application
Oncology
Infectious Diseases
Psychiatry
Cardiovascular
Others
By Company
Abbott Laboratories
Admera Health, LLC
Mesa Laboratories, Inc.
Dynamic DNA Laboratories
F. Hoffmann-La Roche Ltd.
GeneOmbio Technologies Pvt Ltd.
Exact Sciences Corporation
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
OmeCare
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
Precipio
23andMe, Inc.
OneOme, LLC
DiaCarta, Inc.
OPKO Health
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacogenomics Services Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Genotyping
1.2.3 SNP Identification
1.2.4 Pharmacogenetic Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmacogenomics Services Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Infectious Diseases
1.3.4 Psychiatry
1.3.5 Cardiovascular
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmacogenomics Services Market Perspective (2017-2028)
2.2 Pharmacogenomics Services Growth Trends by Region
2.2.1 Pharmacogenomics Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pharmacogenomics Services Historic Market Size by Region (2017-2022)
2.2.3 Pharmacogenomics Services Forecasted Market Size by Region (2023-2028)
2.3 Pharmacogenomics Services Market Dynamics
2.3.1 Pharmacogenomics Services Industry Trends
2.3.2 Pharmacogenomics Services Market Drivers
2.3.3 Pharmacogenomics Services Market Challenges
2.3.4 Pharmacogenomics Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacogenomics Services Players by Revenue
3.1.1 Global Top Pharmacogenomics Services Players by Revenue (2017-2022)
3.1.2 Global Pharmacogenomics Services Revenue Market Share by Players (2017-2022)
3.2 Global Pharmacogenomics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacogenomics Services Revenue
3.4 Global Pharmacogenomics Services Market Concentration Ratio
3.4.1 Global Pharmacogenomics Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacogenomics Services Revenue in 2021
3.5 Pharmacogenomics Services Key Players Head office and Area Served
3.6 Key Players Pharmacogenomics Services Product Solution and Service
3.7 Date of Enter into Pharmacogenomics Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacogenomics Services Breakdown Data by Type
4.1 Global Pharmacogenomics Services Historic Market Size by Type (2017-2022)
4.2 Global Pharmacogenomics Services Forecasted Market Size by Type (2023-2028)
5 Pharmacogenomics Services Breakdown Data by Application
5.1 Global Pharmacogenomics Services Historic Market Size by Application (2017-2022)
5.2 Global Pharmacogenomics Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pharmacogenomics Services Market Size (2017-2028)
6.2 North America Pharmacogenomics Services Market Size by Type
6.2.1 North America Pharmacogenomics Services Market Size by Type (2017-2022)
6.2.2 North America Pharmacogenomics Services Market Size by Type (2023-2028)
6.2.3 North America Pharmacogenomics Services Market Share by Type (2017-2028)
6.3 North America Pharmacogenomics Services Market Size by Application
6.3.1 North America Pharmacogenomics Services Market Size by Application (2017-2022)
6.3.2 North America Pharmacogenomics Services Market Size by Application (2023-2028)
6.3.3 North America Pharmacogenomics Services Market Share by Application (2017-2028)
6.4 North America Pharmacogenomics Services Market Size by Country
6.4.1 North America Pharmacogenomics Services Market Size by Country (2017-2022)
6.4.2 North America Pharmacogenomics Services Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pharmacogenomics Services Market Size (2017-2028)
7.2 Europe Pharmacogenomics Services Market Size by Type
7.2.1 Europe Pharmacogenomics Services Market Size by Type (2017-2022)
7.2.2 Europe Pharmacogenomics Services Market Size by Type (2023-2028)
7.2.3 Europe Pharmacogenomics Services Market Share by Type (2017-2028)
7.3 Europe Pharmacogenomics Services Market Size by Application
7.3.1 Europe Pharmacogenomics Services Market Size by Application (2017-2022)
7.3.2 Europe Pharmacogenomics Services Market Size by Application (2023-2028)
7.3.3 Europe Pharmacogenomics Services Market Share by Application (2017-2028)
7.4 Europe Pharmacogenomics Services Market Size by Country
7.4.1 Europe Pharmacogenomics Services Market Size by Country (2017-2022)
7.4.2 Europe Pharmacogenomics Services Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacogenomics Services Market Size (2017-2028)
8.2 Asia-Pacific Pharmacogenomics Services Market Size by Type
8.2.1 Asia-Pacific Pharmacogenomics Services Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pharmacogenomics Services Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pharmacogenomics Services Market Share by Type (2017-2028)
8.3 Asia-Pacific Pharmacogenomics Services Market Size by Application
8.3.1 Asia-Pacific Pharmacogenomics Services Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pharmacogenomics Services Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pharmacogenomics Services Market Share by Application (2017-2028)
8.4 Asia-Pacific Pharmacogenomics Services Market Size by Region
8.4.1 Asia-Pacific Pharmacogenomics Services Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pharmacogenomics Services Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmacogenomics Services Market Size (2017-2028)
9.2 Latin America Pharmacogenomics Services Market Size by Type
9.2.1 Latin America Pharmacogenomics Services Market Size by Type (2017-2022)
9.2.2 Latin America Pharmacogenomics Services Market Size by Type (2023-2028)
9.2.3 Latin America Pharmacogenomics Services Market Share by Type (2017-2028)
9.3 Latin America Pharmacogenomics Services Market Size by Application
9.3.1 Latin America Pharmacogenomics Services Market Size by Application (2017-2022)
9.3.2 Latin America Pharmacogenomics Services Market Size by Application (2023-2028)
9.3.3 Latin America Pharmacogenomics Services Market Share by Application (2017-2028)
9.4 Latin America Pharmacogenomics Services Market Size by Country
9.4.1 Latin America Pharmacogenomics Services Market Size by Country (2017-2022)
9.4.2 Latin America Pharmacogenomics Services Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacogenomics Services Market Size (2017-2028)
10.2 Middle East & Africa Pharmacogenomics Services Market Size by Type
10.2.1 Middle East & Africa Pharmacogenomics Services Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pharmacogenomics Services Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pharmacogenomics Services Market Share by Type (2017-2028)
10.3 Middle East & Africa Pharmacogenomics Services Market Size by Application
10.3.1 Middle East & Africa Pharmacogenomics Services Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pharmacogenomics Services Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pharmacogenomics Services Market Share by Application (2017-2028)
10.4 Middle East & Africa Pharmacogenomics Services Market Size by Country
10.4.1 Middle East & Africa Pharmacogenomics Services Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pharmacogenomics Services Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Pharmacogenomics Services Introduction
11.1.4 Abbott Laboratories Revenue in Pharmacogenomics Services Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 Admera Health, LLC
11.2.1 Admera Health, LLC Company Details
11.2.2 Admera Health, LLC Business Overview
11.2.3 Admera Health, LLC Pharmacogenomics Services Introduction
11.2.4 Admera Health, LLC Revenue in Pharmacogenomics Services Business (2017-2022)
11.2.5 Admera Health, LLC Recent Developments
11.3 Mesa Laboratories, Inc.
11.3.1 Mesa Laboratories, Inc. Company Details
11.3.2 Mesa Laboratories, Inc. Business Overview
11.3.3 Mesa Laboratories, Inc. Pharmacogenomics Services Introduction
11.3.4 Mesa Laboratories, Inc. Revenue in Pharmacogenomics Services Business (2017-2022)
11.3.5 Mesa Laboratories, Inc. Recent Developments
11.4 Dynamic DNA Laboratories
11.4.1 Dynamic DNA Laboratories Company Details
11.4.2 Dynamic DNA Laboratories Business Overview
11.4.3 Dynamic DNA Laboratories Pharmacogenomics Services Introduction
11.4.4 Dynamic DNA Laboratories Revenue in Pharmacogenomics Services Business (2017-2022)
11.4.5 Dynamic DNA Laboratories Recent Developments
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Details
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Pharmacogenomics Services Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.6 GeneOmbio Technologies Pvt Ltd.
11.6.1 GeneOmbio Technologies Pvt Ltd. Company Details
11.6.2 GeneOmbio Technologies Pvt Ltd. Business Overview
11.6.3 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Introduction
11.6.4 GeneOmbio Technologies Pvt Ltd. Revenue in Pharmacogenomics Services Business (2017-2022)
11.6.5 GeneOmbio Technologies Pvt Ltd. Recent Developments
11.7 Exact Sciences Corporation
11.7.1 Exact Sciences Corporation Company Details
11.7.2 Exact Sciences Corporation Business Overview
11.7.3 Exact Sciences Corporation Pharmacogenomics Services Introduction
11.7.4 Exact Sciences Corporation Revenue in Pharmacogenomics Services Business (2017-2022)
11.7.5 Exact Sciences Corporation Recent Developments
11.8 Illumina, Inc.
11.8.1 Illumina, Inc. Company Details
11.8.2 Illumina, Inc. Business Overview
11.8.3 Illumina, Inc. Pharmacogenomics Services Introduction
11.8.4 Illumina, Inc. Revenue in Pharmacogenomics Services Business (2017-2022)
11.8.5 Illumina, Inc. Recent Developments
11.9 Laboratory Corporation of America Holdings
11.9.1 Laboratory Corporation of America Holdings Company Details
11.9.2 Laboratory Corporation of America Holdings Business Overview
11.9.3 Laboratory Corporation of America Holdings Pharmacogenomics Services Introduction
11.9.4 Laboratory Corporation of America Holdings Revenue in Pharmacogenomics Services Business (2017-2022)
11.9.5 Laboratory Corporation of America Holdings Recent Developments
11.10 Myriad Genetics, Inc.
11.10.1 Myriad Genetics, Inc. Company Details
11.10.2 Myriad Genetics, Inc. Business Overview
11.10.3 Myriad Genetics, Inc. Pharmacogenomics Services Introduction
11.10.4 Myriad Genetics, Inc. Revenue in Pharmacogenomics Services Business (2017-2022)
11.10.5 Myriad Genetics, Inc. Recent Developments
11.11 OmeCare
11.11.1 OmeCare Company Details
11.11.2 OmeCare Business Overview
11.11.3 OmeCare Pharmacogenomics Services Introduction
11.11.4 OmeCare Revenue in Pharmacogenomics Services Business (2017-2022)
11.11.5 OmeCare Recent Developments
11.12 QIAGEN N.V.
11.12.1 QIAGEN N.V. Company Details
11.12.2 QIAGEN N.V. Business Overview
11.12.3 QIAGEN N.V. Pharmacogenomics Services Introduction
11.12.4 QIAGEN N.V. Revenue in Pharmacogenomics Services Business (2017-2022)
11.12.5 QIAGEN N.V. Recent Developments
11.13 Quest Diagnostics Incorporated
11.13.1 Quest Diagnostics Incorporated Company Details
11.13.2 Quest Diagnostics Incorporated Business Overview
11.13.3 Quest Diagnostics Incorporated Pharmacogenomics Services Introduction
11.13.4 Quest Diagnostics Incorporated Revenue in Pharmacogenomics Services Business (2017-2022)
11.13.5 Quest Diagnostics Incorporated Recent Developments
11.14 Thermo Fisher Scientific Inc.
11.14.1 Thermo Fisher Scientific Inc. Company Details
11.14.2 Thermo Fisher Scientific Inc. Business Overview
11.14.3 Thermo Fisher Scientific Inc. Pharmacogenomics Services Introduction
11.14.4 Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Services Business (2017-2022)
11.14.5 Thermo Fisher Scientific Inc. Recent Developments
11.15 Precipio
11.15.1 Precipio Company Details
11.15.2 Precipio Business Overview
11.15.3 Precipio Pharmacogenomics Services Introduction
11.15.4 Precipio Revenue in Pharmacogenomics Services Business (2017-2022)
11.15.5 Precipio Recent Developments
11.16 23andMe, Inc.
11.16.1 23andMe, Inc. Company Details
11.16.2 23andMe, Inc. Business Overview
11.16.3 23andMe, Inc. Pharmacogenomics Services Introduction
11.16.4 23andMe, Inc. Revenue in Pharmacogenomics Services Business (2017-2022)
11.16.5 23andMe, Inc. Recent Developments
11.17 OneOme, LLC
11.17.1 OneOme, LLC Company Details
11.17.2 OneOme, LLC Business Overview
11.17.3 OneOme, LLC Pharmacogenomics Services Introduction
11.17.4 OneOme, LLC Revenue in Pharmacogenomics Services Business (2017-2022)
11.17.5 OneOme, LLC Recent Developments
11.18 DiaCarta, Inc.
11.18.1 DiaCarta, Inc. Company Details
11.18.2 DiaCarta, Inc. Business Overview
11.18.3 DiaCarta, Inc. Pharmacogenomics Services Introduction
11.18.4 DiaCarta, Inc. Revenue in Pharmacogenomics Services Business (2017-2022)
11.18.5 DiaCarta, Inc. Recent Developments
11.19 OPKO Health
11.19.1 OPKO Health Company Details
11.19.2 OPKO Health Business Overview
11.19.3 OPKO Health Pharmacogenomics Services Introduction
11.19.4 OPKO Health Revenue in Pharmacogenomics Services Business (2017-2022)
11.19.5 OPKO Health Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Pharmacogenomics Services Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Genotyping
Table 3. Key Players of SNP Identification
Table 4. Key Players of Pharmacogenetic Testing
Table 5. Key Players of Others
Table 6. Global Pharmacogenomics Services Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Pharmacogenomics Services Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Pharmacogenomics Services Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Pharmacogenomics Services Market Share by Region (2017-2022)
Table 10. Global Pharmacogenomics Services Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Pharmacogenomics Services Market Share by Region (2023-2028)
Table 12. Pharmacogenomics Services Market Trends
Table 13. Pharmacogenomics Services Market Drivers
Table 14. Pharmacogenomics Services Market Challenges
Table 15. Pharmacogenomics Services Market Restraints
Table 16. Global Pharmacogenomics Services Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Pharmacogenomics Services Revenue Share by Players (2017-2022)
Table 18. Global Top Pharmacogenomics Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Services as of 2021)
Table 19. Ranking of Global Top Pharmacogenomics Services Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Pharmacogenomics Services Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pharmacogenomics Services Product Solution and Service
Table 23. Date of Enter into Pharmacogenomics Services Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmacogenomics Services Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Pharmacogenomics Services Revenue Market Share by Type (2017-2022)
Table 27. Global Pharmacogenomics Services Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Pharmacogenomics Services Revenue Market Share by Type (2023-2028)
Table 29. Global Pharmacogenomics Services Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Pharmacogenomics Services Revenue Share by Application (2017-2022)
Table 31. Global Pharmacogenomics Services Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Pharmacogenomics Services Revenue Share by Application (2023-2028)
Table 33. North America Pharmacogenomics Services Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Pharmacogenomics Services Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Pharmacogenomics Services Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Pharmacogenomics Services Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Pharmacogenomics Services Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Pharmacogenomics Services Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Pharmacogenomics Services Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Pharmacogenomics Services Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Pharmacogenomics Services Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Pharmacogenomics Services Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Pharmacogenomics Services Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Pharmacogenomics Services Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Pharmacogenomics Services Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Pharmacogenomics Services Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Pharmacogenomics Services Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Pharmacogenomics Services Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Pharmacogenomics Services Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Pharmacogenomics Services Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Pharmacogenomics Services Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Pharmacogenomics Services Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Pharmacogenomics Services Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Pharmacogenomics Services Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Pharmacogenomics Services Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Pharmacogenomics Services Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Pharmacogenomics Services Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Pharmacogenomics Services Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Pharmacogenomics Services Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Pharmacogenomics Services Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Pharmacogenomics Services Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Pharmacogenomics Services Market Size by Country (2023-2028) & (US$ Million)
Table 63. Abbott Laboratories Company Details
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Pharmacogenomics Services Product
Table 66. Abbott Laboratories Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 67. Abbott Laboratories Recent Developments
Table 68. Admera Health, LLC Company Details
Table 69. Admera Health, LLC Business Overview
Table 70. Admera Health, LLC Pharmacogenomics Services Product
Table 71. Admera Health, LLC Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 72. Admera Health, LLC Recent Developments
Table 73. Mesa Laboratories, Inc. Company Details
Table 74. Mesa Laboratories, Inc. Business Overview
Table 75. Mesa Laboratories, Inc. Pharmacogenomics Services Product
Table 76. Mesa Laboratories, Inc. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 77. Mesa Laboratories, Inc. Recent Developments
Table 78. Dynamic DNA Laboratories Company Details
Table 79. Dynamic DNA Laboratories Business Overview
Table 80. Dynamic DNA Laboratories Pharmacogenomics Services Product
Table 81. Dynamic DNA Laboratories Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 82. Dynamic DNA Laboratories Recent Developments
Table 83. F. Hoffmann-La Roche Ltd. Company Details
Table 84. F. Hoffmann-La Roche Ltd. Business Overview
Table 85. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product
Table 86. F. Hoffmann-La Roche Ltd. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 87. F. Hoffmann-La Roche Ltd. Recent Developments
Table 88. GeneOmbio Technologies Pvt Ltd. Company Details
Table 89. GeneOmbio Technologies Pvt Ltd. Business Overview
Table 90. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product
Table 91. GeneOmbio Technologies Pvt Ltd. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 92. GeneOmbio Technologies Pvt Ltd. Recent Developments
Table 93. Exact Sciences Corporation Company Details
Table 94. Exact Sciences Corporation Business Overview
Table 95. Exact Sciences Corporation Pharmacogenomics Services Product
Table 96. Exact Sciences Corporation Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 97. Exact Sciences Corporation Recent Developments
Table 98. Illumina, Inc. Company Details
Table 99. Illumina, Inc. Business Overview
Table 100. Illumina, Inc. Pharmacogenomics Services Product
Table 101. Illumina, Inc. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 102. Illumina, Inc. Recent Developments
Table 103. Laboratory Corporation of America Holdings Company Details
Table 104. Laboratory Corporation of America Holdings Business Overview
Table 105. Laboratory Corporation of America Holdings Pharmacogenomics Services Product
Table 106. Laboratory Corporation of America Holdings Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 107. Laboratory Corporation of America Holdings Recent Developments
Table 108. Myriad Genetics, Inc. Company Details
Table 109. Myriad Genetics, Inc. Business Overview
Table 110. Myriad Genetics, Inc. Pharmacogenomics Services Product
Table 111. Myriad Genetics, Inc. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 112. Myriad Genetics, Inc. Recent Developments
Table 113. OmeCare Company Details
Table 114. OmeCare Business Overview
Table 115. OmeCare Pharmacogenomics Services Product
Table 116. OmeCare Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 117. OmeCare Recent Developments
Table 118. QIAGEN N.V. Company Details
Table 119. QIAGEN N.V. Business Overview
Table 120. QIAGEN N.V. Pharmacogenomics Services Product
Table 121. QIAGEN N.V. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 122. QIAGEN N.V. Recent Developments
Table 123. Quest Diagnostics Incorporated Company Details
Table 124. Quest Diagnostics Incorporated Business Overview
Table 125. Quest Diagnostics Incorporated Pharmacogenomics Services Product
Table 126. Quest Diagnostics Incorporated Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 127. Quest Diagnostics Incorporated Recent Developments
Table 128. Thermo Fisher Scientific Inc. Company Details
Table 129. Thermo Fisher Scientific Inc. Business Overview
Table 130. Thermo Fisher Scientific Inc. Pharmacogenomics Services Product
Table 131. Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 132. Thermo Fisher Scientific Inc. Recent Developments
Table 133. Precipio Company Details
Table 134. Precipio Business Overview
Table 135. Precipio Pharmacogenomics Services Product
Table 136. Precipio Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 137. Precipio Recent Developments
Table 138. 23andMe, Inc. Company Details
Table 139. 23andMe, Inc. Business Overview
Table 140. 23andMe, Inc. Pharmacogenomics Services Product
Table 141. 23andMe, Inc. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 142. 23andMe, Inc. Recent Developments
Table 143. OneOme, LLC Company Details
Table 144. OneOme, LLC Business Overview
Table 145. OneOme, LLC Pharmacogenomics Services Product
Table 146. OneOme, LLC Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 147. OneOme, LLC Recent Developments
Table 148. DiaCarta, Inc. Company Details
Table 149. DiaCarta, Inc. Business Overview
Table 150. DiaCarta, Inc. Pharmacogenomics Services Product
Table 151. DiaCarta, Inc. Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 152. DiaCarta, Inc. Recent Developments
Table 153. OPKO Health Company Details
Table 154. OPKO Health Business Overview
Table 155. OPKO Health Pharmacogenomics Services Product
Table 156. OPKO Health Revenue in Pharmacogenomics Services Business (2017-2022) & (US$ Million)
Table 157. OPKO Health Recent Developments
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacogenomics Services Market Share by Type: 2021 VS 2028
Figure 2. Genotyping Features
Figure 3. SNP Identification Features
Figure 4. Pharmacogenetic Testing Features
Figure 5. Others Features
Figure 6. Global Pharmacogenomics Services Market Share by Application: 2021 VS 2028
Figure 7. Oncology Case Studies
Figure 8. Infectious Diseases Case Studies
Figure 9. Psychiatry Case Studies
Figure 10. Cardiovascular Case Studies
Figure 11. Others Case Studies
Figure 12. Pharmacogenomics Services Report Years Considered
Figure 13. Global Pharmacogenomics Services Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Pharmacogenomics Services Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Pharmacogenomics Services Market Share by Region: 2021 VS 2028
Figure 16. Global Pharmacogenomics Services Market Share by Players in 2021
Figure 17. Global Top Pharmacogenomics Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Services as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Pharmacogenomics Services Revenue in 2021
Figure 19. North America Pharmacogenomics Services Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Pharmacogenomics Services Market Size Market Share by Type (2017-2028)
Figure 21. North America Pharmacogenomics Services Market Size Market Share by Application (2017-2028)
Figure 22. North America Pharmacogenomics Services Market Size Share by Country (2017-2028)
Figure 23. United States Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Pharmacogenomics Services Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Pharmacogenomics Services Market Size Market Share by Type (2017-2028)
Figure 27. Europe Pharmacogenomics Services Market Size Market Share by Application (2017-2028)
Figure 28. Europe Pharmacogenomics Services Market Size Share by Country (2017-2028)
Figure 29. Germany Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Pharmacogenomics Services Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Pharmacogenomics Services Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Pharmacogenomics Services Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Pharmacogenomics Services Market Size Share by Region (2017-2028)
Figure 39. China Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Pharmacogenomics Services Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Pharmacogenomics Services Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Pharmacogenomics Services Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Pharmacogenomics Services Market Size Share by Country (2017-2028)
Figure 49. Mexico Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Pharmacogenomics Services Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Pharmacogenomics Services Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Pharmacogenomics Services Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Pharmacogenomics Services Market Size Share by Country (2017-2028)
Figure 55. Turkey Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Pharmacogenomics Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Abbott Laboratories Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 59. Admera Health, LLC Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 60. Mesa Laboratories, Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 61. Dynamic DNA Laboratories Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 62. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 63. GeneOmbio Technologies Pvt Ltd. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 64. Exact Sciences Corporation Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 65. Illumina, Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 66. Laboratory Corporation of America Holdings Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 67. Myriad Genetics, Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 68. OmeCare Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 69. QIAGEN N.V. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 70. Quest Diagnostics Incorporated Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 71. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 72. Precipio Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 73. 23andMe, Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 74. OneOme, LLC Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 75. DiaCarta, Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 76. OPKO Health Revenue Growth Rate in Pharmacogenomics Services Business (2017-2022)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed


★調査レポート[ファーマコゲノミクス（PGx）サービスの世界市場インサイト・予測（～2028年）] (コード：QY22JLX09275)販売に関する免責事項を必ずご確認ください。
★調査レポート[ファーマコゲノミクス（PGx）サービスの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 5G技術・サービスの世界市場インサイト・予測（～2028年）
  • ジェノタイピングアッセイの世界市場インサイト・予測（～2028年）
  • ペット用外科サービスの世界市場インサイト・予測（～2028年）
  • 家庭用インフュージョンサービスの世界市場インサイト・予測（～2028年）
  • メタボロミクスサービスの世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆